]>
IRCT20160306026938N11 IRCT 2022-09-15 Tehran University of Medical Sciences Comparison the clinical effect of berry extract and Desmopressin in primary mono symptomatic nocturnal enuresis Study the clinical effect of berry extract and comparison with Desmopressin in 6-12 children with primary mono symptomatic nocturnal enuresis 2022-07-22 anticipated 70 Complete https://irct.ir/trial/22203 interventional Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. N/A Mono-symptomatic nocturnal enuresis. Intervention 1: Intervention group: Berry hydroalcoholic extract syrup (7.5 ml twice a day), is equal to 20 grams of fruit per day, for 2 consecutive weeks. Intervention 2: Cََontrol group: Desmopressin (nasal spray 10 microgram per dose) administration based on medical practitioner order for 4 consecutive weeks. Yes - There is a plan to make this available What will be shared: Demographic specification of patients, would be published, except their names and address. Primary outcome of the patients would be published, too. When: Data would be available 6 months after publishing the results To whom: Data would be available for researchers in academic and scientific organisations Conditions: Any type of usage of data is allowable, except using for manufacturing a product Where to obtain: Sending an E. mail to mehdivazirian@gmail.com How to obtain: After receiving E. mail, data would be sent within a week Comments:
public Mahdi Vazirian
Faculty of pharmacy, 16th Azar Ave., Enqelab Ave.
Tehran Iran (Islamic Republic of) 1417614411 +98 21 6412 1223 Vazirian_m@tums.ac.ir Tehran University of Medical Sciences scientific Mahdi Vazirian
Faculty of pharmacy, 16th Azar Ave., Enqelab Ave.
Tehran Iran (Islamic Republic of) 1417614315 +98 21 6412 1223 vazirian_m@tums.ac.ir Tehran University of Medical Sciences Iran (Islamic Republic of) Children between 6-12 years old Satisfied parents for participating in study. Not suffered from incurable and underlying disease Suffered from mono symptomatic nocturnal enuresis 6 years 12 years Both Children out of range 6-12 years old Lack of permission of parents for participating in study Suffered from incurable and underlying disease Not suffered from mono symptomatic nocturnal enuresis N39.44 Overflow Reflex Urge incontinence Treatment - Drugs Treatment - Drugs Intervention group: Berry hydroalcoholic extract syrup (7.5 ml twice a day), is equal to 20 grams of fruit per day, for 2 consecutive weeks Cََontrol group: Desmopressin (nasal spray 10 microgram per dose) administration based on medical practitioner order for 4 consecutive weeks Frequency of wet nights in a weekchildren. Timepoint: Before intervention and 4 weeks after beginning the intervention and 2 weeks after cessation of intervention. Method of measurement: Parent’s report in questionnaire. Tehran University of Medical Sciences Approved 2022-04-14 Ethics committee of Investigation Center of Chronic Kidney Diseases in children Children medical clinic, Next to the Imam Khomeini Hospital, Dr Gharib Avenue, Keshavarz Blvd Tehran Tehran Iran (Islamic Republic of)